Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma

The study will investigate whether liver transplantation provides increased survival, low side effects and good quality of life in patients with bile duct cancer where the tumor cannot be removed by normal surgery. Analyzes of blood and tissue samples from the tumor will be investigated to see if the analyzes can indicate who may have recurrence of the disease after liver transplantation. Furthermore, the effect of chemotherapy on normal liver and tumor tissues in the liver that are removed during transplantation will be investigated.

Trial Details

NCT ID
NCT04993131
Phase
NA
Sponsor
Oslo University Hospital
Status
RECRUITING
Cancer Type
Cholangiocarcinoma (Bile Duct) Liver Cancer
Interventions
  • Liver transplant
Locations (sample)
  • Oslo, Norway|59.91273,10.74609

Key Eligibility Criteria

  • Radiologically strong suspicion of pCCA
  • Tumor can involve intrahepatic portal vein without thrombosis of extrahepatic portal vein
  • Tumor can involve hepatic artery distal to gastroduodenal artery or involve replaced hepatic artery
  • First time pCCA

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Cholangiocarcinoma (Bile Duct) Liver Cancer Trials on Trialify →